Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1996 Feb;64(2):489–494. doi: 10.1128/iai.64.2.489-494.1996

Orally administered microencapsulated Bordetella pertussis fimbriae protect mice from B. pertussis respiratory infection.

D H Jones 1, B W McBride 1, C Thornton 1, D T O'Hagan 1, A Robinson 1, G H Farrar 1
PMCID: PMC173791  PMID: 8550197

Abstract

Fimbriae from Bordetella pertussis have been encapsulated in poly(lactide-co-glycolide) microparticles of a size appropriate for uptake by the immune inductive tissues of the gastrointestinal tract. Mice were immunized by oral gavage with a single dose of 10 micrograms of microencapsulated fimbriae. The resulting immune responses were compared with those resulting from intraperitoneal injection of mice with equivalent amounts of fimbriae absorbed onto alhydrogel. The examination of serum and mucosal secretions, collected over a 6-week period, for specific antifimbrial antibodies clearly demonstrated that only orally immunized animals mounted measurable immune responses in external secretions. Six weeks after immunization, all immunized animals were protected against intranasal challenge with live B. pertussis.

Full Text

The Full Text of this article is available as a PDF (236.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bockman D. E., Cooper M. D. Pinocytosis by epithelium associated with lymphoid follicles in the bursa of Fabricius, appendix, and Peyer's patches. An electron microscopic study. Am J Anat. 1973 Apr;136(4):455–477. doi: 10.1002/aja.1001360406. [DOI] [PubMed] [Google Scholar]
  2. Brownlie R. M., Brahmbhatt H. N., White D. C., Fountain M. W., Rohde M., Wehland J., Timmis K. N. Stimulation of secretory antibodies against Bordetella pertussis antigens in the lungs of mice after oral or intranasal administration of liposome-incorporated cell-surface antigens. Microb Pathog. 1993 Feb;14(2):149–160. doi: 10.1006/mpat.1993.1015. [DOI] [PubMed] [Google Scholar]
  3. Cahill E. S., O'Hagan D. T., Illum L., Barnard A., Mills K. H., Redhead K. Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles. Vaccine. 1995 Apr;13(5):455–462. doi: 10.1016/0264-410x(94)00008-b. [DOI] [PubMed] [Google Scholar]
  4. Cahill E. S., O'Hagan D. T., Illum L., Redhead K. Mice are protected against Bordetella pertussis infection by intra-nasal immunization with filamentous haemagglutinin. FEMS Microbiol Lett. 1993 Mar 1;107(2-3):211–216. doi: 10.1111/j.1574-6968.1993.tb06032.x. [DOI] [PubMed] [Google Scholar]
  5. Challacombe S. J., Rahman D., Jeffery H., Davis S. S., O'Hagan D. T. Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen. Immunology. 1992 May;76(1):164–168. [PMC free article] [PubMed] [Google Scholar]
  6. Challacombe S. J. Salivary antibodies and systemic tolerance in mice after oral immunization with bacterial antigens. Ann N Y Acad Sci. 1983 Jun 30;409:177–193. doi: 10.1111/j.1749-6632.1983.tb26868.x. [DOI] [PubMed] [Google Scholar]
  7. Cleland J. L., Powell M. F., Lim A., Barrón L., Berman P. W., Eastman D. J., Nunberg J. H., Wrin T., Vennari J. C. Development of a single-shot subunit vaccine for HIV-1. AIDS Res Hum Retroviruses. 1994;10 (Suppl 2):S21–S26. [PubMed] [Google Scholar]
  8. Curtiss R., 3rd, Kelly S. M., Gulig P. A., Nakayama K. Selective delivery of antigens by recombinant bacteria. Curr Top Microbiol Immunol. 1989;146:35–49. doi: 10.1007/978-3-642-74529-4_4. [DOI] [PubMed] [Google Scholar]
  9. Eldridge J. H., Gilley R. M., Staas J. K., Moldoveanu Z., Meulbroek J. A., Tice T. R. Biodegradable microspheres: vaccine delivery system for oral immunization. Curr Top Microbiol Immunol. 1989;146:59–66. doi: 10.1007/978-3-642-74529-4_6. [DOI] [PubMed] [Google Scholar]
  10. Eldridge J. H., Meulbroek J. A., Staas J. K., Tice T. R., Gilley R. M. Vaccine-containing biodegradable microspheres specifically enter the gut-associated lymphoid tissue following oral administration and induce a disseminated mucosal immune response. Adv Exp Med Biol. 1989;251:191–202. doi: 10.1007/978-1-4757-2046-4_18. [DOI] [PubMed] [Google Scholar]
  11. Eldridge J. H., Staas J. K., Meulbroek J. A., McGhee J. R., Tice T. R., Gilley R. M. Biodegradable microspheres as a vaccine delivery system. Mol Immunol. 1991 Mar;28(3):287–294. doi: 10.1016/0161-5890(91)90076-v. [DOI] [PubMed] [Google Scholar]
  12. Eldridge J. H., Staas J. K., Meulbroek J. A., Tice T. R., Gilley R. M. Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies. Infect Immun. 1991 Sep;59(9):2978–2986. doi: 10.1128/iai.59.9.2978-2986.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Elson C. O., Ealding W., Lefkowitz J. A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions. J Immunol Methods. 1984 Feb 24;67(1):101–108. doi: 10.1016/0022-1759(84)90089-9. [DOI] [PubMed] [Google Scholar]
  14. Esparza I., Kissel T. Parameters affecting the immunogenicity of microencapsulated tetanus toxoid. Vaccine. 1992;10(10):714–720. doi: 10.1016/0264-410x(92)90094-z. [DOI] [PubMed] [Google Scholar]
  15. Holmgren J., Lycke N., Czerkinsky C. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine. 1993 Sep;11(12):1179–1184. doi: 10.1016/0264-410x(93)90039-z. [DOI] [PubMed] [Google Scholar]
  16. Holmgren J., Svennerholm A. M. Development of oral vaccines against cholera and enterotoxinogenic Escherichia coli diarrhea. Scand J Infect Dis Suppl. 1990;76:47–53. [PubMed] [Google Scholar]
  17. Hora M. S., Rana R. K., Nunberg J. H., Tice T. R., Gilley R. M., Hudson M. E. Release of human serum albumin from poly(lactide-co-glycolide) microspheres. Pharm Res. 1990 Nov;7(11):1190–1194. doi: 10.1023/a:1015948829632. [DOI] [PubMed] [Google Scholar]
  18. Jackson S., Mestecky J., Childers N. K., Michalek S. M. Liposomes containing anti-idiotypic antibodies: an oral vaccine to induce protective secretory immune responses specific for pathogens of mucosal surfaces. Infect Immun. 1990 Jun;58(6):1932–1936. doi: 10.1128/iai.58.6.1932-1936.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Jani P., Halbert G. W., Langridge J., Florence A. T. Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J Pharm Pharmacol. 1990 Dec;42(12):821–826. doi: 10.1111/j.2042-7158.1990.tb07033.x. [DOI] [PubMed] [Google Scholar]
  20. Jones D. H., McBride B. W., Jeffery H., O'Hagan D. T., Robinson A., Farrar G. H. Protection of mice from Bordetella pertussis respiratory infection using microencapsulated pertussis fimbriae. Vaccine. 1995 May;13(7):675–681. doi: 10.1016/0264-410x(95)99876-j. [DOI] [PubMed] [Google Scholar]
  21. Maloy K. J., Donachie A. M., O'Hagan D. T., Mowat A. M. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles. Immunology. 1994 Apr;81(4):661–667. [PMC free article] [PubMed] [Google Scholar]
  22. Marx P. A., Compans R. W., Gettie A., Staas J. K., Gilley R. M., Mulligan M. J., Yamshchikov G. V., Chen D., Eldridge J. H. Protection against vaginal SIV transmission with microencapsulated vaccine. Science. 1993 May 28;260(5112):1323–1327. doi: 10.1126/science.8493576. [DOI] [PubMed] [Google Scholar]
  23. McQueen C. E., Boedeker E. C., Reid R., Jarboe D., Wolf M., Le M., Brown W. R. Pili in microspheres protect rabbits from diarrhoea induced by E. coli strain RDEC-1. Vaccine. 1993;11(2):201–206. doi: 10.1016/0264-410x(93)90018-s. [DOI] [PubMed] [Google Scholar]
  24. Menge A. C., Michalek S. M., Russell M. W., Mestecky J. Immune response of the female rat genital tract after oral and local immunization with keyhole limpet hemocyanin conjugated to the cholera toxin B subunit. Infect Immun. 1993 May;61(5):2162–2171. doi: 10.1128/iai.61.5.2162-2171.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Mestecky J. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol. 1987 Jul;7(4):265–276. doi: 10.1007/BF00915547. [DOI] [PubMed] [Google Scholar]
  26. Modlin J. F. Mucosal immunity following oral poliovirus vaccine and enhanced potency inactivated poliovirus vaccine immunization. Pediatr Infect Dis J. 1991 Dec;10(12):976–978. doi: 10.1097/00006454-199112000-00031. [DOI] [PubMed] [Google Scholar]
  27. Moldoveanu Z., Novak M., Huang W. Q., Gilley R. M., Staas J. K., Schafer D., Compans R. W., Mestecky J. Oral immunization with influenza virus in biodegradable microspheres. J Infect Dis. 1993 Jan;167(1):84–90. doi: 10.1093/infdis/167.1.84. [DOI] [PubMed] [Google Scholar]
  28. Moldoveanu Z., Staas J. K., Gilley R. M., Ray R., Compans R. W., Eldridge J. H., Tice T. R., Mestecky J. Immune responses to influenza virus in orally and systemically immunized mice. Curr Top Microbiol Immunol. 1989;146:91–99. doi: 10.1007/978-3-642-74529-4_10. [DOI] [PubMed] [Google Scholar]
  29. Neutra M. R., Phillips T. L., Mayer E. L., Fishkind D. J. Transport of membrane-bound macromolecules by M cells in follicle-associated epithelium of rabbit Peyer's patch. Cell Tissue Res. 1987 Mar;247(3):537–546. doi: 10.1007/BF00215747. [DOI] [PubMed] [Google Scholar]
  30. O'Hagan D. T., Jeffery H., Roberts M. J., McGee J. P., Davis S. S. Controlled release microparticles for vaccine development. Vaccine. 1991 Oct;9(10):768–771. doi: 10.1016/0264-410x(91)90295-h. [DOI] [PubMed] [Google Scholar]
  31. O'Hagan D. T., McGee J. P., Holmgren J., Mowat A. M., Donachie A. M., Mills K. H., Gaisford W., Rahman D., Challacombe S. J. Biodegradable microparticles for oral immunization. Vaccine. 1993;11(2):149–154. doi: 10.1016/0264-410x(93)90011-l. [DOI] [PubMed] [Google Scholar]
  32. O'Hagan D. T., Palin K. J., Davis S. S. Poly(butyl-2-cyanoacrylate) particles as adjuvants for oral immunization. Vaccine. 1989 Jun;7(3):213–216. doi: 10.1016/0264-410x(89)90231-4. [DOI] [PubMed] [Google Scholar]
  33. O'Hagan D. T., Rahman D., McGee J. P., Jeffery H., Davies M. C., Williams P., Davis S. S., Challacombe S. J. Biodegradable microparticles as controlled release antigen delivery systems. Immunology. 1991 Jun;73(2):239–242. [PMC free article] [PubMed] [Google Scholar]
  34. Owen R. L., Ermak T. H. Structural specializations for antigen uptake and processing in the digestive tract. Springer Semin Immunopathol. 1990;12(2-3):139–152. doi: 10.1007/BF00197502. [DOI] [PubMed] [Google Scholar]
  35. Pappo J., Ermak T. H. Uptake and translocation of fluorescent latex particles by rabbit Peyer's patch follicle epithelium: a quantitative model for M cell uptake. Clin Exp Immunol. 1989 Apr;76(1):144–148. [PMC free article] [PubMed] [Google Scholar]
  36. Ray R., Novak M., Duncan J. D., Matsuoka Y., Compans R. W. Microencapsulated human parainfluenza virus induces a protective immune response. J Infect Dis. 1993 Mar;167(3):752–755. doi: 10.1093/infdis/167.3.752. [DOI] [PubMed] [Google Scholar]
  37. Roberts M., Cropley I., Chatfield S., Dougan G. Protection of mice against respiratory Bordetella pertussis infection by intranasal immunization with P.69 and FHA. Vaccine. 1993;11(8):866–872. doi: 10.1016/0264-410x(93)90363-3. [DOI] [PubMed] [Google Scholar]
  38. Robinson A., Gorringe A. R., Funnell S. G., Fernandez M. Serospecific protection of mice against intranasal infection with Bordetella pertussis. Vaccine. 1989 Aug;7(4):321–324. doi: 10.1016/0264-410x(89)90193-x. [DOI] [PubMed] [Google Scholar]
  39. Russell M. W., Mestecky J. Induction of the mucosal immune response. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 2):S440–S446. doi: 10.1093/cid/10.supplement_2.s440. [DOI] [PubMed] [Google Scholar]
  40. Shahin R. D., Amsbaugh D. F., Leef M. F. Mucosal immunization with filamentous hemagglutinin protects against Bordetella pertussis respiratory infection. Infect Immun. 1992 Apr;60(4):1482–1488. doi: 10.1128/iai.60.4.1482-1488.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Shahin R., Leef M., Eldridge J., Hudson M., Gilley R. Adjuvanticity and protective immunity elicited by Bordetella pertussis antigens encapsulated in poly(DL-lactide-co-glycolide) microspheres. Infect Immun. 1995 Apr;63(4):1195–1200. doi: 10.1128/iai.63.4.1195-1200.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Shalaby W. S. Development of oral vaccines to stimulate mucosal and systemic immunity: barriers and novel strategies. Clin Immunol Immunopathol. 1995 Feb;74(2):127–134. doi: 10.1006/clin.1995.1019. [DOI] [PubMed] [Google Scholar]
  43. Sneller M. C., Strober W. M cells and host defense. J Infect Dis. 1986 Nov;154(5):737–741. doi: 10.1093/infdis/154.5.737. [DOI] [PubMed] [Google Scholar]
  44. Tacket C. O., Reid R. H., Boedeker E. C., Losonsky G., Nataro J. P., Bhagat H., Edelman R. Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheres. Vaccine. 1994 Nov;12(14):1270–1274. doi: 10.1016/s0264-410x(94)80038-2. [DOI] [PubMed] [Google Scholar]
  45. Uchida T., Martin S., Foster T. P., Wardley R. C., Grimm S. Dose and load studies for subcutaneous and oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin. Pharm Res. 1994 Jul;11(7):1009–1015. doi: 10.1023/a:1018987404751. [DOI] [PubMed] [Google Scholar]
  46. Visscher G. E., Robison R. L., Maulding H. V., Fong J. W., Pearson J. E., Argentieri G. J. Biodegradation of and tissue reaction to 50:50 poly(DL-lactide-co-glycolide) microcapsules. J Biomed Mater Res. 1985 Mar;19(3):349–365. doi: 10.1002/jbm.820190315. [DOI] [PubMed] [Google Scholar]
  47. Walker R. I. New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine. 1994 Apr;12(5):387–400. doi: 10.1016/0264-410x(94)90112-0. [DOI] [PubMed] [Google Scholar]
  48. deVos T., Dick T. A. A rapid method to determine the isotype and specificity of coproantibodies in mice infected with Trichinella or fed cholera toxin. J Immunol Methods. 1991 Aug 9;141(2):285–288. doi: 10.1016/0022-1759(91)90155-9. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES